Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003631171 | SCV001114545 | likely benign | Hyperinsulinism-hyperammonemia syndrome | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000967173 | SCV001144066 | benign | not provided | 2019-03-27 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001819074 | SCV002066689 | uncertain significance | not specified | 2019-04-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004629393 | SCV005123063 | likely benign | Inborn genetic diseases | 2024-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |